AJCN Tufts Nutrition Symposium, Boston & Online Sept 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vieira, V. J
Right arrow Articles by Tagliaferro, A. R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vieira, V. J
Right arrow Articles by Tagliaferro, A. R
Agricola
Right arrow Articles by Vieira, V. J
Right arrow Articles by Tagliaferro, A. R
American Journal of Clinical Nutrition, Vol. 82, No. 3, 504-509, September 2005
© 2005 American Society for Clinical Nutrition


ORIGINAL RESEARCH COMMUNICATION

Elevated atopy in healthy obese women1,2,3,4,5

Victoria J Vieira, Anne M Ronan, Mark R Windt and Anthony R Tagliaferro

1 From the Department of Animal and Nutritional Sciences, University of New Hampshire, Durham, NH (VJV, AMR, MRW, and ART)

Background: Allergic disorders, including asthma, have increased dramatically in the United States in the past 20 y. Epidemiologic studies have found body mass index (body weight in kg/height squared in m) to be a positive independent correlate of atopy in women but not in men.

Objective: We investigated the prevalence of atopy among healthy obese and nonobese women and its relation to fat mass (FM), insulin resistance, and plasma concentrations of 17ß-estradiol, interleukin 4 (IL-4), and leptin.

Design: A cross-sectional study of 21 obese (≥30% body fat) and 22 nonobese (<30% body fat) women (18–41 y of age) was performed. The following measurements were taken: FM by plethysmography, total and specific immunoglobulin E (IgE) by automated immunosorbent analysis, and blood glucose, insulin, C-peptide, 17ß-estradiol, sex hormone–binding globulin, and IL-4. Insulin sensitivity was determined on the basis of the fasting insulin resistance index and with an oral-glucose-tolerance test.

Results: The frequency of specific IgE in the obese group was almost 3 times that in the nonobese group (P = 0.008). The total IgE concentration was not significantly different between groups. Plasma concentrations of 17ß-estradiol, the ratio of 17ß-estradiol to sex hormone–binding globulin, the fasting insulin resistance index, and C-peptide and leptin concentrations were higher in the obese than in the nonobese group (P < 0.05) after adjustment for oral contraceptive use. All factors correlated positively with FM. Logistic regression showed FM to be the only positive predictor of specific IgE (P = 0.01).

Conclusion: The findings confirm a direct relation between obesity and a T helper 2 cell immune response in women.

Key Words: Allergy • obesity • leptin • atopy • insulin resistance • 17ß-estradiol







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by The American Society for Nutrition